Unknown

Dataset Information

0

Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair.


ABSTRACT: Adoptive T cell therapy using T-cell receptor (TCR)-engineered T cells allows to redirect T cell specificity and to target any antigen of interest. Here, we apply advanced genetic engineering using clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) for simultaneous editing of TCR α- and β-chains in primary human T cells. Together with non-virally delivered template DNA, this CRISPR-Cas9-system allows for elimination of the endogenous TCR and orthotopic placement of TCR α- and β-chains. For complete details on the use and execution of this protocol, please refer to Schober et al. (2019) and Müller et al. (2021).

SUBMITTER: Moosmann C 

PROVIDER: S-EPMC8683654 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5566437 | biostudies-other
| S-EPMC7144937 | biostudies-literature
| S-EPMC8484621 | biostudies-literature
| S-EPMC7005300 | biostudies-literature
| S-EPMC8835944 | biostudies-literature
| S-EPMC4339809 | biostudies-other
2018-06-04 | E-MTAB-6808 | biostudies-arrayexpress
| S-EPMC3982687 | biostudies-literature
| S-EPMC6970138 | biostudies-literature
| S-EPMC7747451 | biostudies-literature